DNLI Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:55):
Our systems believe the stock currently is overvalued by -0.04% compare to its pairs and should correct downwards.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States...

Stats
Dagens volum	470 390
Gjennomsnittsvolum	1.16M
Markedsverdi	3.14B
EPS	$-0.680 ( Q1 \| 2024-05-07 )
Neste inntjeningsdato	( $-0.700 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-23.41 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0370 (0.17%)

AADI -5.59%

ABCL 1.28%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 1.63%

ABSI 4.08%

ABUS -1.15%

ABVX -3.00%

ACAD -0.58%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 3.02%

ACIU -0.62%

ACLX -0.52%

ACRV -4.13%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -3.72%

ADGI 0.87%

ADIL -2.63%

ADMA -1.41%

ADPT 0.44%

ADTX -3.47%

ADVM 0.94%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.15%

AGEN -4.44%

AGIO -2.86%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.19%

AKRO -2.21%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.69%

ALGS -1.96%

ALKS 1.82%

ALLK -11.44%

ALLO -3.13%

ALLR -2.69%

ALNA 3.16%

ALNY 2.19%

ALPN 0.02%

ALPX 0.00%

ALRN -2.17%

ALT -15.18%

ALVR -0.58%

ALXN 0.00%

ALXO -10.50%

ALZN 5.10%

AMRN -4.06%

AMTI -3.13%

ANAB 1.51%

ANEB 9.62%

ANGN 0.00%

ANIX -3.25%

ANL -0.14%

ANNX 2.18%

ANPC -3.15%

APGE 1.76%

APGN 8.48%

APGNW 30.65%

APLM -3.68%

APLS 0.42%

APLT -0.45%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 3.30%

ARAV -13.39%

ARCT -6.89%

ARDS -12.13%

ARDX 1.74%

ARGX -1.17%

ARNA 0.00%

ARPO -0.90%

ARQT -3.91%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.70%

ARWR -2.38%

ASLN -2.45%

ASMB -7.03%

ASND -2.81%

ATAI -3.69%

ATHA 8.22%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 2.91%

ATRA -5.94%

ATXI 1.09%

ATXS -0.23%

AUPH -0.99%

AURA 4.70%

AUTL -3.17%

AVBP -3.60%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE 0.00%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -1.81%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.37%

BCAB -7.17%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.56%

BCTX 13.27%

BCTXW 1.97%

BCYC 0.80%

BDRX -5.55%

BDTX -0.32%

BEAM 2.47%

BFRA -2.91%

BGNE -2.82%

BIOR -3.93%

BIVI 2.50%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -1.07%

BLU 0.03%

BLUE -4.44%

BMEA -14.88%

BMRN 0.34%

BNOX 4.46%

BNTC -2.95%

BNTX -2.25%

BOLD -11.06%

BOLT 0.32%

BPMC -2.38%

BPTH -5.24%

BPTS -13.47%

BRNS -0.37%

BRTX -6.23%

BTAI 13.98%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.75%

CABA 0.90%

CADL 1.24%

CALA 0.00%

CALC -0.04%

CALT -1.59%

CAPR -0.22%

CARA -11.98%

CARM 6.54%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.13%

CCXI 0.00%

CDAK 0.00%

CDIO -4.66%

CDIOW 24.00%

CDMO -1.34%

CDMOP 0.04%

CDT -4.13%

CDTTW -39.60%

CDTX -6.19%

CDXC 9.00%

CDXS 9.48%

CELC -3.06%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.52%

CERO -5.00%

CEROW -10.18%

CFRX -27.95%

CGEM 0.18%

CGEN -3.58%

CGON -2.96%

CGTX -3.41%

CHMA -6.00%

CHRS 4.76%

CINC 0.00%

CING -3.91%

CINGW 34.95%

CKPT -1.67%

CLBS -16.75%

CLDX -0.30%

CLGN -0.50%

CLLS -3.11%

CLNN -2.22%

CLNNW 0.00%

CLRB 7.24%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.26%

CMPI 0.00%

CMPX 0.94%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.45%

CNCE 0.00%

CNSP -33.52%

CNST 0.00%

CNTA 0.90%

CNTB -1.50%

CNTX -8.92%

COCP -1.84%

COEPW 32.45%

COGT -3.13%

CORT 3.82%

COYA -2.44%

CPRX -0.96%

CRBP -1.45%

CRBU -7.95%

CRDF 3.10%

CRGX -1.48%

CRIS -2.64%

CRNX -6.04%

CRSP 1.22%

CRTX 2.63%

CRVO -9.18%

CRVS 0.70%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -1.65%

CTNM 7.12%

CTXR -5.97%

CUE -3.11%

CVAC -5.08%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 20.01%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.50%

CYTO 0.00%

DARE 0.86%

DAWN -0.07%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 31.42%

DNLI -1.70%

DNTH -2.39%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.71%

DTIL 1.56%

DYAI 8.39%

EARS -1.77%

EDIT -2.92%

EDSA 4.14%

EFTR -0.93%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.14%

ELEV -1.87%

ELOX 10.77%

ELTX -3.38%

ELVN -1.16%

ELYM 6.97%

ENGN 0.49%

ENGNW -21.67%

ENLV 0.74%

ENOB 1.79%

ENSC 6.55%

ENTA -0.33%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -0.82%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 7.21%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.55%

ETON 2.44%

ETTX 0.00%

EVAX 0.00%

EVGN 3.46%

EVLO 0.00%

EWTX 0.72%

EXAI -0.38%

EXEL 0.67%

EYEG -0.69%

EYEN 0.00%

EYPT -0.36%

FATE -12.25%

FBIO 0.59%

FBIOP 0.87%

FBLG -10.96%

FBRX -0.04%

FDMT -4.52%

FENC -3.06%

FGEN -10.21%

FHTX 7.50%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.77%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.85%

FULC 3.01%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -1.54%

GBIO -1.06%

GBT 0.01%

GDTC 2.03%

GERN -1.66%

GHRS -4.27%

GLMD -2.48%

GLPG -1.83%

GLSI 9.27%

GLTO -3.90%

GLUE -2.51%

GLYC -15.02%

GMAB -0.45%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -3.98%

GNPX -4.41%

GNTA 3.94%

GOSS -6.94%

GOVX -7.24%

GOVXW 10.89%

GPCR -6.11%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.20%

GRTX -1.66%

GTHX 2.05%

GUTS 0.35%

GXGXW 41.67%

GYRE -6.71%

HALO -0.72%

HARP 0.09%

HCWB -3.76%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX 0.65%

HOOK 0.47%

HOTH -3.78%

HOWL 0.21%

HRMY 3.36%

HRTX 8.36%

HSTO 0.00%

HUMA 1.72%

HUMAW -6.25%

IBRX -6.40%

ICCC -2.10%

ICPT 0.21%

ICU 19.21%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.32%

IFRX -3.40%

IGMS -2.19%

IKNA -2.97%

IKT -2.08%

IMAB -0.58%

IMCR -3.78%

IMGN 0.02%

IMGO 0.00%

IMMP 5.31%

IMMX -4.17%

IMNM 3.90%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -2.81%

IMTX -1.33%

IMTXW 6.00%

IMUX -6.54%

IMV 0.00%

IMVT -4.14%

INAB -1.12%

INBX -3.28%

INCY -2.16%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.07%

INMB 0.98%

INO 1.95%

INSM -1.02%

INTS -3.73%

INVA 0.81%

INZY 1.37%

IOBT -7.09%

IONS 1.53%

IOVA -3.96%

IPA 1.08%

IPHA 2.54%

IPSC -2.34%

IRON -1.73%

ISEE 0.38%

ITOS 2.60%

ITRM 1.36%

IVA 6.96%

IVVD 0.00%

JAGX 0.26%

JANX -4.58%

JAZZ -0.86%

JNCE 0.00%

JSPR -2.25%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.49%

KALV -2.51%

KDNY 0.22%

KMPH -0.34%

KNSA -2.37%

KNTE -0.38%

KOD -9.09%

KPRX -5.76%

KPTI -8.55%

KRBP -10.00%

KRON 1.64%

KROS -0.42%

KRRO -1.59%

KRTX 0.03%

KRYS 1.16%

KTRA 9.28%

KTTA -0.65%

KTTAW 0.92%

KURA 0.68%

KYMR -3.88%

KYTX -5.56%

KZIA 6.21%

KZR -1.51%

LABP 0.57%

LBPH 1.13%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.24%

LENZ -3.67%

LEXX 0.58%

LEXXW -14.63%

LGND -1.05%

LGNDV 0.00%

LGVN -9.13%

LIAN -8.28%

LIFE 2.70%

LIPO -7.29%

LIXT -10.19%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.35%

LPCN -4.36%

LPTX -0.55%

LQDA 0.33%

LRMR -0.64%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -5.15%

LXEO -13.33%

LXRX -0.88%

LYEL -35.83%

LYRA 4.22%

MACK 0.10%

MBIO -10.82%

MBRX -1.43%

MCRB 0.60%

MDGL -1.99%

MDNA -13.16%

MDWD 3.36%

MDXG -1.62%

MEIP 0.70%

MESO -1.48%

MGNX -5.48%

MGTA -7.74%

MGTX 0.95%

MGX 2.28%

MIRM -0.42%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.98%

MLYS -8.87%

MNKD -0.67%

MNMD 3.68%

MNOV 1.41%

MNPR -9.34%

MOLN 0.76%

MOR 0.62%

MORF -3.01%

MREO 0.29%

MRKR -0.43%

MRNA -11.17%

MRNS -6.27%

MRSN -3.81%

MRTX -0.17%

MRUS 0.83%

MRVI 1.38%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -5.25%

MYMD 2.16%

NAMS 0.41%

NAMSW 0.64%

NAUT -1.54%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -0.32%

NEXI 1.50%

NGM -1.28%

NGNE 3.01%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.40%

NKTX -2.93%

NLSP 5.57%

NLSPW 26.67%

NMRA -1.37%

NMTR -42.97%

NOVN -24.84%

NRBO 12.45%

NRIX -1.68%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.58%

NTRBW -31.07%

NUVL -2.02%

NVAX -6.11%

NVCT -7.80%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO 0.29%

OBSV 0.00%

OCEA -3.52%

OCGN 6.78%

OCS -1.00%

OCUL 0.69%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.99%

OMER -2.57%

OMGA -2.92%

ONCO 6.17%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.47%

ONTX -0.47%

ONVO 1.01%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.41%

ORMP 15.44%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.69%

OVID 0.44%

OYST 0.00%

PALI -0.48%

PASG -0.22%

PBLA -7.50%

PBM -3.47%

PBYI 4.56%

PCSA 0.00%

PCVX 0.68%

PDSB -4.58%

PEPG 1.43%

PGEN -6.66%

PHAR 1.99%

PHAS 0.00%

PHAT -0.10%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.38%

PLUR 10.34%

PMN -5.55%

PMVP -0.90%

PNT 0.16%

PPBT 1.64%

PRAX 5.35%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 2.02%

PRQR 1.20%

PRTA -3.42%

PRTC 6.52%

PRTG 0.09%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -13.94%

PSTX -4.46%

PTCT -0.48%

PTE -0.82%

PTGX 0.03%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.09%

QLGN -5.84%

QNCX 2.23%

QNRX 0.84%

QSI -28.46%

QSIAW -9.44%

QTTB 4.54%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -1.79%

RARE 2.06%

RCKT -10.41%

REGN -0.19%

RENB -3.11%

REPL -1.98%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.35%

RGLS -5.37%

RGNX -6.45%

RIGL -6.24%

RLAY -6.34%

RLMD -0.33%

RLYB -5.70%

RNA 2.57%

RNAC 2.25%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.08%

ROIVW 4.56%

RPHM -1.24%

RPRX -0.99%

RPTX -1.47%

RUBY 2.70%

RVLP -32.05%

RVMD -1.16%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.35%

RYTM -6.37%

RYZB 0.02%

RZLT 2.33%

SABS -1.37%

SABSW -5.53%

SAGE -0.64%

SANA -2.68%

SAVA -3.81%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.29%

SCPH 11.87%

SCPS 0.00%

SEEL -3.16%

SEER -0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.93%

SGMT -4.83%

SGTX -2.56%

SIOX 22.63%

SLDB -2.33%

SLGL 5.23%

SLN -8.57%

SLNO 1.64%

SLRX 0.40%

SLS -4.27%

SMMT -3.18%

SNDX 2.02%

SNGX 4.45%

SNPX -2.77%

SONN -1.59%

SPPI -0.49%

SPRB -1.79%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.69%

SRRA 0.00%

SRRK -2.73%

SRZN -2.45%

STAB 0.00%

STOK -7.09%

STRO -1.84%

STSA 0.00%

STTK 7.02%

SURF -0.93%

SVRA -2.24%

SWTX -0.43%

SYBX 0.00%

SYRS -1.72%

TALS -0.73%

TARA -6.74%

TARS -2.01%

TBPH 0.24%

TCBP 9.98%

TCDA 0.00%

TCON -1.34%

TCRR 0.00%

TCRT 4.49%

TCRX -1.54%

TECH -1.31%

TENX -0.89%

TERN -6.82%

TFFP -11.68%

TGTX -7.56%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -4.16%

TNXP -10.04%

TNYA -5.96%

TPST 4.13%

TRDA -4.77%

TRVI 1.92%

TRVN 0.49%

TSHA -16.72%

TSVT -4.39%

TTNP -6.20%

TVTX 3.71%

TYRA -7.01%

UBX -2.73%

UNCY -4.00%

URGN 4.37%

UTHR -0.06%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.72%

VCNX 5.44%

VCYT -1.06%

VERA -4.46%

VERU 1.40%

VERV -3.82%

VIGL 1.34%

VINC 2.81%

VIR -1.25%

VIRI -5.42%

VIRX 0.31%

VKTX -0.86%

VLON -13.04%

VNDA -2.61%

VOR -6.45%

VRCA 0.14%

VRDN -3.13%

VRNA -1.60%

VRPX 3.58%

VRTX 0.00%

VSTM 4.76%

VTGN -2.31%

VTVT 1.28%

VTYX -2.72%

VXRT -1.48%

VYGR -0.51%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -7.86%

XBIO 1.03%

XBIT 5.23%

XCUR 0.23%

XENE -1.26%

XERS 5.00%

XFOR 5.76%

XLO 4.41%

XLRN 0.00%

XNCR 0.31%

XOMA -6.93%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.56%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -1.55%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-06	Cook Jennifer E.	Sell	1 458	Common Stock
2024-05-31	Krognes Steve E.	Buy	5 967	Common Stock
2024-05-31	Krognes Steve E.	Buy	17 901	Stock Option (right to buy)
2024-05-31	Thornberry Nancy	Buy	5 967	Common Stock
2024-05-31	Thornberry Nancy	Buy	17 901	Stock Option (right to buy)

INSIDER POWER
48.53
Last 100 transactions
Buy: 1 318 628 \| Sell: 476 183

Korrelasjon (AI algo v.1.1b): Overvalued: -0.04% $22.00 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.15 (neutral)

Kort: 0.59 (weak)

Signal:(68.901) Neutral

Denali Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Denali Therapeutics Inc Korrelasjon - Valuta/Råvare

-0.58
( weak negative )

-0.51
( weak negative )

0.00
( neutral )

-0.37
( neutral )

-0.55
( weak negative )

-0.43
( neutral )

Denali Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$330.53M
Bruttogevinst:	$313.81M (94.94 %)
EPS:	$-1.060

FY	2023
Omsetning:	$330.53M
Bruttogevinst:	$313.81M (94.94 %)
EPS:	$-1.060

FY	2022
Omsetning:	$108.46M
Bruttogevinst:	$101.43M (93.52 %)
EPS:	$-2.60

FY	2021
Omsetning:	$48.66M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.40

Financial Reports:

No articles found.

Denali Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Denali Therapeutics Inc

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreement with Takeda Pharmaceutical Company, Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. to develop antisense therapies in the field of neurodegenerative diseases. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.